Dec 31, 2021

ANI Pharmaceuticals Q4 2021 Earnings Report

Total Revenue
$60.9M
Previous year: $57.3M
+6.4%
EPS
$0.54
Previous year: $0.8
-32.5%
Generics Revenue Growth
41,600,000%
Gross Profit
$27M
Previous year: $32.7M
-17.4%
Cash and Equivalents
$100M
Previous year: $7.9M
+1169.6%
Free Cash Flow
-$12.5M
Previous year: -$7.82M
+60.4%
Total Assets
$772M
Previous year: $95.8M
+705.4%

ANI Pharmaceuticals

ANI Pharmaceuticals

ANI Pharmaceuticals Revenue by Segment

Revenue & Expenses

Visualization of income flow from segment revenue to net income